DE60224145D1 - Suplatast tosilat kristalle - Google Patents

Suplatast tosilat kristalle

Info

Publication number
DE60224145D1
DE60224145D1 DE60224145T DE60224145T DE60224145D1 DE 60224145 D1 DE60224145 D1 DE 60224145D1 DE 60224145 T DE60224145 T DE 60224145T DE 60224145 T DE60224145 T DE 60224145T DE 60224145 D1 DE60224145 D1 DE 60224145D1
Authority
DE
Germany
Prior art keywords
suplatast tosilate
crystal
tosilate crystals
suplatast
tosilate crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60224145T
Other languages
English (en)
Other versions
DE60224145T2 (de
Inventor
Takanori Ushio
Hidenori Miura
Keiko Nagai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of DE60224145D1 publication Critical patent/DE60224145D1/de
Application granted granted Critical
Publication of DE60224145T2 publication Critical patent/DE60224145T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/12—Sulfonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE60224145T 2001-04-16 2002-04-16 Suplatasttosilat-kristall Expired - Lifetime DE60224145T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001117165 2001-04-16
JP2001117165 2001-04-16
PCT/JP2002/003762 WO2002083633A1 (fr) 2001-04-16 2002-04-16 Cristaux de tosilate de suplatast

Publications (2)

Publication Number Publication Date
DE60224145D1 true DE60224145D1 (de) 2008-01-31
DE60224145T2 DE60224145T2 (de) 2008-12-11

Family

ID=18967782

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60224145T Expired - Lifetime DE60224145T2 (de) 2001-04-16 2002-04-16 Suplatasttosilat-kristall

Country Status (16)

Country Link
US (1) US7138140B2 (de)
EP (1) EP1295870B1 (de)
JP (1) JP4015954B2 (de)
KR (1) KR100535305B1 (de)
CN (1) CN1205182C (de)
AT (1) ATE381538T1 (de)
AU (1) AU2002248036B2 (de)
CA (1) CA2413087C (de)
CY (1) CY1107112T1 (de)
DE (1) DE60224145T2 (de)
DK (1) DK1295870T3 (de)
ES (1) ES2298358T3 (de)
HK (1) HK1059773A1 (de)
PT (1) PT1295870E (de)
TW (1) TWI241289B (de)
WO (1) WO2002083633A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005260954B2 (en) * 2004-07-13 2011-04-07 Taiho Pharmaceutical Co., Ltd. Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same
JP4794148B2 (ja) * 2004-09-10 2011-10-19 大鵬薬品工業株式会社 ネフローゼ症候群治療剤
JP4498101B2 (ja) * 2004-11-04 2010-07-07 大鵬薬品工業株式会社 頭痛の予防及び／または治療剤
WO2007001058A1 (ja) * 2005-06-27 2007-01-04 Juntendo Educational Foundation ヘルペスウイルス由来疼痛治療剤
EP2103305B1 (de) * 2006-12-26 2011-09-28 Taiho Pharmaceutical Co., Ltd. Therapeutisches mittel gegen diabetische neuropathie
CA3073866A1 (en) * 2017-08-29 2019-03-07 Conrig Pharma Aps Composition comprising suplatast tosilate
EP3813817A4 (de) * 2018-06-27 2022-08-10 Algernon Pharmaceuticals Inc. Verwendung von actarit in der prophylaxe oder behandlung von nierenfibrose oder nierenerkrankung
CN110824088B (zh) * 2019-11-26 2022-04-12 重庆柳江医药科技有限公司 利用hplc-ms测定甲磺司特在血浆中含量的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
DE4107857A1 (de) * 1991-03-12 1992-09-17 Thomae Gmbh Dr K Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
TW264385B (de) * 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
JP3256376B2 (ja) * 1994-01-27 2002-02-12 大鵬薬品工業株式会社 トシル酸スプラタストの結晶およびその製造方法
JP3563480B2 (ja) 1994-03-10 2004-09-08 大鵬薬品工業株式会社 光学活性体の製造方法、並びに光学活性なスルホニウム化合物
CA2192576A1 (en) * 1995-04-24 1996-10-31 Fuminori Tokumochi Remedy for allergic diseases in the region of the nose
US5965565A (en) * 1996-12-12 1999-10-12 Merck & Co., Inc. Piperidines promote release of growth hormone
JP3634622B2 (ja) 1998-05-01 2005-03-30 大鵬薬品工業株式会社 腎透析に伴うそう痒の治療剤
WO2000027383A1 (fr) * 1998-11-05 2000-05-18 Taiho Pharmaceutical Co., Ltd. Medicaments contre la dysurie

Also Published As

Publication number Publication date
WO2002083633A1 (fr) 2002-10-24
HK1059773A1 (en) 2004-07-16
PT1295870E (pt) 2008-01-10
AU2002248036B2 (en) 2005-04-21
ATE381538T1 (de) 2008-01-15
JP4015954B2 (ja) 2007-11-28
DK1295870T3 (da) 2008-01-28
CN1461297A (zh) 2003-12-10
ES2298358T3 (es) 2008-05-16
CA2413087A1 (en) 2002-12-16
EP1295870B1 (de) 2007-12-19
CY1107112T1 (el) 2012-10-24
KR100535305B1 (ko) 2005-12-08
TWI241289B (en) 2005-10-11
JPWO2002083633A1 (ja) 2004-08-05
DE60224145T2 (de) 2008-12-11
US20030149105A1 (en) 2003-08-07
CA2413087C (en) 2008-03-11
US7138140B2 (en) 2006-11-21
EP1295870A1 (de) 2003-03-26
EP1295870A4 (de) 2006-01-18
CN1205182C (zh) 2005-06-08
KR20030029051A (ko) 2003-04-11

Similar Documents

Publication Publication Date Title
CY1107112T1 (el) Κρυσταλλοι τοζιλικου suplatast
MXPA04003936A (es) Cristal en forma alfa o en forma beta de derivado de acetanilida.
TNSN94079A1 (fr) Une nouvelle forme de compose
MY138452A (en) Novel process for synthesizing and a novel crystal form of agomelatine as well as pharmaceutical preparations containing these
NZ508842A (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
KR880001226A (ko) 유용성물질함유 고상물의 제조방법
DK1270575T3 (da) Hidtil ukendt krystallinsk form af et pyrrolidylthiocarbapenemderivat
KR950010910A (ko) 내포 복합체
NO20016381D0 (no) Dinukleotidkrystaller
NO20011634L (no) Krystall av diuridintetrafosfat eller salter derav, og fremgangsmåte for fremstilling av samme og fremgangsmåte forfremstilling av nevnte forbindelse
FI955285A (fi) Suuria kaliumvetykarbonaattikiteitä ja menetelmä niiden valmistamiseksi
DE69124330D1 (de) Optisch aktive Thienotriazolodiazepin-Verbindungen
Jayaraman et al. A high-pressure Raman study of KReO4, RbReO4 and CsReO4 to 25 GPa and pressure-induced phase transitions
PT91361A (pt) Processo aperfeicoado para a preparacao de diamidas de acidos n,n'-bis- -(alcoxialquil)-piridina-2,4-dicarboxilicos e de composicoes farmaceuticas que as contem
US3895242A (en) Non-linear optical elements
Jiang et al. Growth of zinc cadmium thiocyanate single crystal for laser diode frequency-doubling
PE20010209A1 (es) Polimorfos de un citrato de azobiciclo[2,2,2] octan-3-amina y sus composiciones farmaceuticas
Siddheswaran et al. Growth and characterization of tris allylthiourea mercuric chloride crystals
CA2000184C (en) Trihydrates of sodium l- and d-2-pyrrolidone-5-carboxylate
JPS6434927A (en) Method for asymmetric photochemical reaction
PT1462439E (pt) Novos cristais estáveis de derivado do ácido fenilpropiónico substituído e processo para a sua produção
CO4410182A1 (es) Proceso para mejorar la pureza enantiomerica de aldehidos
TH50989A (th) รูปผลึกที่ vii ของคาเบอร์โกลีน
JPS6475450A (en) Optically active compound
ATE328869T1 (de) Stabile kristalle von pyrrolverbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition